Cactus
FDA Label NDC 60986-1021

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Cactus (NDC 60986-1021). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, otc - keep out of reach of children, suggested use, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

CACTUS GRANDIFLORUS 2XHPUS

CONVALLARIA MAJALIS 3XHPUS

CRATAEGUS LAEVIGATA 1XHPUS

CAMPHORA 2XHPUS

KALMIA LATIFOLIA 4XHPUS

SPIGELIA ANTHELMIA 4XHPUS

LACHESIS MUTUS 8XHPUS

ARNICA MONTANA 6XHPUS

TABACUM 8XHPUS

GLONOINUM 8XHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

FOR RELIEF OF CHEST PAIN DUE TO STRESS; ANGINA PECTORIS; MYOCARDIAL INSUFFICIENCY; TOBACCO ABUSE.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Suggested Use

Error

Warnings

If pregnant or breast-feeding, consult a health professional before use.

Dosage & Administration

(Read Suggested Use Section)

* Please review the disclaimer below.